Writing away HIV risk: trauma therapy boosts PrEP in Drug-Using women
NCT ID NCT05192434
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called TIARAS, which combines a reward system for staying drug-free and on PrEP (HIV prevention pills or shots) with expressive writing about past trauma. The goal is to see if this approach lowers HIV risk in women who inject drugs. 219 women from Philadelphia clinics took part over 12 months, with researchers tracking PrEP adherence and risky behaviors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Prevention Point Philadelphia
Philadelphia, Pennsylvania, 19143, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop anal lesions from becoming cancer?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Hidden risk: could opioid misuse be overlooked in cancer care?
- Can mindfulness curb opioid use after injury?
- Can resilience defeat HIV stigma? a new study investigates
- Peer support may curb HIV stigma and stress in vietnamese gay men